Seminar : Next Generation Sequencing Leads to the Next Multi-Omics Era |
Other events...
|
Shanghai Personal Biotechnology Co. Ltd. (hereinafter referred to as “Personalbio”) was established in 2011. Headquartered in Shanghai, Personalbio owns high-throughput sequencing platforms including Illumina MiSeq, HiSeq 2500, NextSeq 500, X-ten, NoraSeq and PacBio RS II & Sequel. Led and supported by experts from national and international institutions, Personalbio provides services including next generation sequencing, genetic testing, product development and more. Personalbio has been building a series of personal gene examination packages to improve people’s health management capability and quality of life. Using the Illumina sequencing platforms and reagent certified by FDA, Personalbio collects saliva sample from clients, extract DNA to analyze genetic information. The information is then processed through the internationally recognized genome database (OMIM, NCBI, UCSC etc.), checked with professional research literatures and international norms and standards (NCI, FDA, ACMG etc.). Based on these analyses, Personalbio is able to provide predictions of health risks and advice accordingly for clients at the genetic level. Personalbio has collaboration partners throughout China and is now keen to seek international collaboration.
Speaker(s) |
Dr Zhengsheng Xue
|
Location |
Room 1022, North Agriculture Building, UWA Crawley Campus
|
|
Contact |
SChen1702
<[email protected]>
: 64885928
|
Start |
Mon, 02 Oct 2017 10:00
|
End |
Mon, 02 Oct 2017 11:00
|
Submitted by |
SChen1702 <[email protected]>
|
Last Updated |
Tue, 19 Sep 2017 11:20
|
Included in the following Calendars: |
|
- Locations of venues on the Crawley and Nedlands campuses are
available via the Campus Maps website.
- Download this event as:
Text |
iCalendar
-
Mail this event:
|